Почетна › Колоректални карцином › Тексас › San Antonio
Kliničke studije za Колоректални карцином u gradu San Antonio, TX
43 studija za Колоректални карцином traži učesnike na lokacijama u gradu San Antonio i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1
- UT Health San Antonio's Mays Cancer Center, San Antonio
A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Тражи се учесникФаза 1
- NEXT Oncology, San Antonio
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1
- START San Antonio, San Antonio
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Тражи се учесникФаза 1
- NEXT Texas LLC - San Antonio, San Antonio
- START San Antonio, LLC, San Antonio
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1
- START San Antonio, San Antonio
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
Тражи се учесникФаза 3
- Texas Oncology- San Antonio, San Antonio
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- Audie L Murphy VA Hospital, San Antonio
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
Тражи се учесникФаза 1/2
- NEXT Oncology, San Antonio
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Тражи се учесникФаза 3
- Texas Oncology - San Antonio, San Antonio
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Тражи се учесникФаза 3
- Texas Oncology - San Antonio, San Antonio
A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies
Тражи се учесникФаза 1
- START San Antonio, San Antonio
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
Тражи се учесникФаза 1
- NEXT Oncology, San Antonio
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Тражи се учесникФаза 1
- Research Site #2, San Antonio
- Research Site, San Antonio
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Тражи се учесникФаза 2/3
- Texas Oncology - San Antonio, San Antonio
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
Тражи се учесникФаза 1/2
- GSK Investigational Site, San Antonio
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
Тражи се учесникФаза 2
- Mays Cancer Center at University of Texas Health at San Antonio, San Antonio
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Тражи се учесникФаза 1/2
- START San Antonio, San Antonio
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- Clinical Trial Site, San Antonio
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Тражи се учесникФаза 1/2
- New Experimental Therapeutics of San Antonio - NEXT Oncology, San Antonio
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Тражи се учесникФаза 1
- University of Texas San Antonio (UTSA), San Antonio
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Тражи се учесникФаза 1/2
- NEXT Oncology San Antonio, San Antonio
- START Texas, San Antonio
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Тражи се учесникФаза 1
- NEXT, San Antonio
- START - San Antonio, San Antonio
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1
- NEXT Oncology, San Antonio
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
Тражи се учесникФаза 1
- NEXT San Antonio, San Antonio
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Тражи се учесникФаза 1
- NEXT Oncology, San Antonio
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- UT Health Mays Cancer Center, San Antonio
IDOV-Immune for Advanced Solid Tumors
Тражи се учесникФаза 1
- South Texas Accelerated Research Therapeutics, San Antonio
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1
- Next Oncology, San Antonio
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Тражи се учесникФаза 1
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1
- START San Antonio, LLC., San Antonio
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
Тражи се учесникФаза 1
- New Experimental Therapeutics of San Antonio LLC, San Antonio
- START - South Texas Accelerated Research Therapeutics, LLC, San Antonio
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
Тражи се учесникФаза 1/2
- Next Oncology-Oncology, San Antonio
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Тражи се учесникФаза 1
- START, San Antonio
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
Тражи се учесникФаза 1
- NEXT Oncology, San Antonio
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Тражи се учесникФаза 1/2
- NEXT Oncology, San Antonio
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Тражи се учесникФаза 1/2
- Next Oncology, San Antonio
A Study of MGC028 in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1
- South Texas Accelerated Research Therapeutics (START) San Antonio, San Antonio
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Тражи се учесникФаза 1/2
- NEXT Oncology, San Antonio
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
Тражи се учесникФаза 1
- NEXT Oncology, San Antonio
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- START San Antonio, San Antonio
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Тражи се учесникФаза 1/2
- START San Antonio, San Antonio
Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.
Тражи се учесникФаза 1/2
- Next Oncology, San Antonio, San Antonio
Studije za Колоректални карцином u drugim gradovima
- Houston, TX101 студија
- New York City, NY86 студија
- Nashville, TN67 студија
- Boston, MA62 студија
- Los Angeles, CA61 студија
- Arlington, VA54 студија
- St. Louis, MO51 студија
- Philadelphia, PA41 студија
- Grand Rapids, MI40 студија
- Baldwin Park, CA37 студија
- Tampa, FL36 студија
- Seattle, WA35 студија
Ostale studije u gradu San Antonio
- Немалоклетни карцином плућа60 студија
- Рак дојке45 студија
- Метастатски карцином44 студија
- Рак (све врсте)41 студија
- Гојазност39 студија
- Dijabetes tipa 237 студија
- Гојазност34 студија
- Рак јајника33 студија
- Рак панкреаса33 студија
- Рак плућа27 студија
- Рак простате27 студија
- Карцином ендометријума27 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.